Humanin

Humanin is a 24-amino-acid mitochondrial-derived peptide (MDP) encoded within the mitochondrial 16S rRNA gene (MT-RNR2). It was among the first MDPs characterized and is recognized for cytoprotective signaling activity in experimental systems. The peptide is produced and secreted in response to cellular stress cues and has become a reference molecule for studying how mitochondrial peptides influence cell survival pathways under laboratory conditions.

In cell-based models, Humanin engages extracellular receptors, including the heterotrimeric CNTFR/WSX-1/gp130 complex and formyl peptide receptor-like 1 (FPRL1/FPR2). Intracellularly it can interact with pro-apoptotic factors such as Bax and with IGFBP-3, modulating apoptotic cascade progression. These receptor and protein interactions are linked to activation of pro-survival kinase pathways and attenuation of stress-induced cell death signals studied in vitro.

Humanin is investigated chiefly in cytoprotection, neuroprotection, and metabolic-aging research frameworks. Experimental work examines how the peptide influences resistance to oxidative, metabolic, and apoptotic stress in cultured cells and isolated tissue preparations. Additional studies explore its role as a signaling node connecting mitochondrial stress responses with extracellular survival pathways in defined laboratory models.

Published laboratory studies report that Humanin can reduce markers of programmed cell death and oxidative damage when applied in controlled in-vitro systems. Work in neuronal and metabolic cell models has documented interactions with receptor complexes that correlate with altered survival-pathway signaling. Findings remain model-system dependent and are used to map peptide–receptor and peptide–protein relationships rather than to establish applied outcomes.

Humanin supplied for research is intended strictly for in-vitro and laboratory investigation and is not for human or animal consumption. Investigators typically reconstitute lyophilized material under sterile conditions and store aliquots according to peptide-stability guidance to limit freeze–thaw degradation. Experimental design should account for peptide concentration ranges, vehicle controls, and receptor or pathway readouts appropriate to the chosen cell or biochemical assay system.